Navigation Links
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
Date:2/25/2008

They're at risk for new blockages within 3 years, study finds

MONDAY, Feb. 25 (HealthDay News) -- People who develop a blood clot in their legs (deep vein thrombosis) or in their lungs (pulmonary embolism) are at risk of developing another blood clot within three years, a new study suggests.

Deep vein thrombosis and pulmonary embolism are known collectively as venous thromboembolism.

Researchers looked at 1,691 people, average age 65, in Worcester, Mass., diagnosed with pulmonary embolism (549) and isolated deep vein thrombosis (1,142) in 1999, 2001 or 2003. During the three-year study, 31 (5.7 percent) of the pulmonary embolism patients had a recurrent clot in the lung, 75 (13.7 percent) had a recurrence of either type of venous thromboemolism, and 82 (14.9 percent) had a major bleeding episode (one that required blood transfusion).

Among the 1,142 patients with isolated deep vein thrombosis, 64 (5.6 percent) developed a pulmonary embolism, 217 (19 percent) had recurrent venous thromboembolism, and 146 (12.8 percent) had a major bleeding episode.

Patients with pulmonary embolism were more likely than those with deep vein thrombosis to die after one month (13 percent vs. 5.4 percent), one year (26 percent vs. 20.3 percent), and three years (35.3 percent vs. 29.6 percent).

"Patients whose course was complicated by major bleeding were more likely to experience recurrent venous thromboemolism or to die at three years than those without these complications," wrote Dr. Frederick A. Spencer, of McMaster University Medical Center in Hamilton, Ontario, Canada.

"Patients who presented with pulmonary embolism had similar rates of subsequent pulmonary embolism or recurrent venous thrombosis compared with patients with isolated deep vein thrombosis," the study authors noted.

"However, rates of recurrent venous thromboembolism and major bleeding after deep vein thrombosis and pulmonary embolism remain unacceptably high in the community setting. Efforts are needed to identify patients most at risk for venous thrombosis-associated complications and to develop better anti-coagulation strategies conducive to long-term use in the community setting," they concluded.

The study was published in the Feb. 25 issue of the Archives of Internal Medicine.

More information

The U.S. National Heart, Lung, and Blood Institute has more about deep vein thrombosis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Feb. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mechanism of blood clot elasticity revealed in high definition
2. Indiana Blood Center Signs BIO-key(R) Contract
3. Current Blood Sugar Control Test Results Inaccurate
4. Another way to grow blood vessels
5. Study identifies another strategy for normalizing tumor blood supply
6. Standard test for blood sugar control not accurate in diabetic dialysis patients
7. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
8. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
9. Blood pressure drug may have added benefit
10. Two Laptop Computers Missing From Lifebloods Main Office
11. Airplane Noise Boosts Blood Pressure Even During Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
Breaking Medicine Technology: